About the journal
Bladder Cancer is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,800 USD. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 2352-3727 · 2352-3735
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,800 USD
- Articles in DOAJ
- 495
- Declared review time
- 20 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.sagepub.com/home/BLC
Index listings
- DOAJ · 2023-09-05
- PUBMED · 2015-03-30
- Indexing
- DOAJ · PUBMED
- APC
- 2,800 USD
- Declared review time (DOAJ)
- 20 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
495
Most recent article
last month
Average review time (journal-declared via DOAJ)
20weeks
Works in OpenAlex
679
Last recorded publication year
2026
h-index
37
i10-index
150
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2025-06-10
- Added to DOAJ
- 2023-09-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 57%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101668567
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Urinary and Genital Oncology Studies
- Urological Disorders and Treatments
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
- Urinary Bladder and Prostate Research
Show all subjects (50)
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Screening and Detection
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Research and Treatments
- Cancer Research and Treatments
- Infectious Disease Case Reports and Treatments
- Infectious Disease Case Reports and Treatments
- Cancer survivorship and care
- Immune responses and vaccinations
- Immune responses and vaccinations
- Tissue Engineering and Regenerative Medicine
- Cancer survivorship and care
- Tissue Engineering and Regenerative Medicine
- Genital Health and Disease
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Genital Health and Disease
- Cancer Genomics and Diagnostics
- Enhanced Recovery After Surgery
- Enhanced Recovery After Surgery
- Cancer Genomics and Diagnostics
- Pelvic floor disorders treatments
- Pelvic floor disorders treatments
Keywords (DOAJ)
- bladder cancer
- urothelial carcinoma
- upper urinary tract cancers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ